Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rallybio Corporation

    NASDAQ: RLYB · Real-Time Price · USD
    0.36
    -0.04 (-8.86%)
    At close: Jun 09, 2025, 3:59 PM

    Rallybio Statistics

    Share Statistics

    Rallybio has 41.61M shares outstanding. The number of shares has increased by 0.39% in one year.

    Shares Outstanding

    n/a
    		 41.61M

    Shares Change (YoY)

    n/a
    		 0.39%

    Shares Change (QoQ)

    n/a
    		 0.3%

    Owned by Institutions (%)

    n/a
    		 72.72%

    Shares Floating

    n/a
    		 19.88M

    Failed to Deliver (FTD) Shares

    n/a
    		 891

    FTD / Avg. Volume

    n/a
    		 0.57%

    Short Selling Information

    The latest short interest is 356.94K, so 0.86% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 356.94K

    Short % of Shares Out

    n/a
    		 0.86%

    Short % of Float

    n/a
    		 1.06%

    Short Ratio (days to cover)

    n/a
    		 4.94

    Valuation Ratios

    The PE ratio is -0.72 and the forward PE ratio is -0.28. Rallybio's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -0.72

    Forward PE

    n/a
    		 -0.28

    PS Ratio

    n/a
    		 65.73

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.68

    P/FCF Ratio

    n/a
    		 -0.85

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Rallybio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.87, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 10.87

    Quick Ratio

    n/a
    		 10.87

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $25,440

    Profits Per Employee

    n/a
    		 $-2,311,000

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.24M

    Effective Tax Rate

    n/a
    		 3.88%

    Stock Price Statistics

    The stock price has increased by -72.97% in the last 52 weeks. The beta is -1.24, so Rallybio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.24

    52-Week Price Change

    n/a
    		 -72.97%

    50-Day Moving Average

    n/a
    		 0.35

    200-Day Moving Average

    n/a
    		 0.81

    Relative Strength Index (RSI)

    n/a
    		 59.96

    Average Volume (20 Days)

    n/a
    		 156,161

    Income Statement

    In the last 12 months, Rallybio had revenue of 636K and earned -57.77M in profits. Earnings per share was -1.33.

    Revenue

    n/a
    		 636K

    Gross Profit

    n/a
    		 505K

    Operating Income

    n/a
    		 -60.5M

    Net Income

    n/a
    		 -57.77M

    EBITDA

    n/a
    		 -60.5M

    EBIT

    n/a
    		 -60.5M

    Earnings Per Share (EPS)

    n/a
    		 -1.33
    Full Income Statement

    Balance Sheet

    The company has 13.9M in cash and 154K in debt, giving a net cash position of 13.75M.

    Cash & Cash Equivalents

    n/a
    		 13.9M

    Total Debt

    n/a
    		 154K

    Net Cash

    n/a
    		 13.75M

    Retained Earnings

    n/a
    		 -293.02M

    Total Assets

    n/a
    		 57.98M

    Working Capital

    n/a
    		 53.47M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -49.28M and capital expenditures 0, giving a free cash flow of -49.28M.

    Operating Cash Flow

    n/a
    		 -49.28M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -49.28M

    FCF Per Share

    n/a
    		 -1.13
    Full Cash Flow Statement

    Margins

    Gross margin is 79.4%, with operating and profit margins of -9511.95% and -9084.12%.

    Gross Margin

    n/a
    		 79.4%

    Operating Margin

    n/a
    		 -9511.95%

    Pretax Margin

    n/a
    		 -9084.12%

    Profit Margin

    n/a
    		 -9084.12%

    EBITDA Margin

    n/a
    		 -9511.95%

    EBIT Margin

    n/a
    		 -9511.95%

    FCF Margin

    n/a
    		 -7748.74%

    Dividends & Yields

    RLYB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RLYB is $15, which is 3650% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 3650%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -7.01

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist